11 Patents
- US124921812025Gem-disubstituted Piperidine Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
CRINETICS PHARMACEUTICALS, Inc.
0 cites - US124798252025Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
CRINETICS PHARMACEUTICALS, Inc.
0 cites - US124798282025Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
CRINETICS PHARMACEUTICALS, Inc.
0 cites - US124668292025Spirocyclic Piperidine Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
CRINETICS PHARMACEUTICALS, Inc.
0 cites - 0 cites
- US120654442024Substituted Tetrazolo[1,5-a]pyrazines and Tetrazolo[1,5-c]pyrimidines as Adenosine Receptor Antagonists
Crossignal Therapeutics, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- US115660152023Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
CRINETICS PHARMACEUTICALS, Inc.
0 cites - US115603692023Crystalline Forms and Processes for the Preparation of Cannabinoid Receptor Modulators
Arena Pharmaceuticals, Inc.
0 cites